Thromboembolism is common in solid tumors but rare in hematological malignancies like acute myeloid leukemia (AML), which can complicate patient treatment, especially when anticoagulation is needed.
A case study of a 54-year-old male revealed extensive thromboembolism, including pulmonary and renal thrombosis, and after treatment started, he was diagnosed with AML.
Anticoagulation therapy was initiated due to the thrombotic events, emphasizing the need for careful monitoring of bleeding and platelet levels during treatment for hematological conditions like AML.